Abstract:AIM: To analyze the clinical efficacy and prognosis of amniotic membrane transplantation(AMT)combined with autologous limbal stem cell transplantation(ALSCT)in treating ocular surface chemical burn(OSCB).
METHODS: A retrospective analysis was conducted on the data of OSCB patients admitted to our hospital from January 2024 to March 2025. Patients were divided into two groups. The control group received ALSCT, while the study group received AMT combined with ALSCT. Propensity score matching was performed using 1∶1 nearest-neighbor matching method. The complete healing time of corneal epithelium, ocular surface repair rate, laboratory indicators, complications and prognostic indicators were compared between the two groups.
RESULTS: Finally, 28 participants(16 males and 12 females)were included in the control group, with an average age of 42.36±8.52 y.Totally 28 participants(18 males and 10 females)were in the study group, with an average age of 41.50±8.37 y. The healing time of corneal epithelium in the study group was earlier than that in the control group(P<0.05). The ocular surface repair rate and best corrected visual acuity(LogMAR)were better than those in the control group(all P<0.05). The incidence of various complications and blindness rate were comparable between the two groups(all P>0.05), and the distribution of corneal limbal stem cell deficiency score in study group was better than the control group(P<0.05). Two weeks after surgery, the levels of vascular endothelial growth factor(VEGF)and transforming growth factor-β 1(TGF-β1)in both groups were higher than those before surgery(all P<0.05), and the levels in the study group were lower than those in the control group(all P<0.05).
CONCLUSION: AMT combined with ALSCT for OSCB can promote complete corneal epithelial healing and ocular surface repair, modulate VEGF and TGF-β1, improve visual acuity, reduce the severity of limbal stem cell deficiency, without increasing complications or the blindness rate.